Radio
Now Playing
Quickyla Radio โ€” Click to play
Open โ†’
3 min left
Back to News

Competition Is Heating Up, but Here's Why Intuitive Surgical Might Still Be the Smartest Bet in MedTech

Written by Reuben Gregg Brewer for The Motley Fool -> Intuitive Surgical makes the da Vinci surgical robot, with 11,710 systems in use globally. Medical device competitors Medtronic and Johnson & Jโ€ฆ

Competition Is Heating Up, but Here's Why Intuitive Surgical Might Still Be the Smartest Bet in MedTech
Nasdaq News โ€” 8 August 2026
Text:
11 0 0

Intuitive Surgical makes the da Vinci surgical robot, with 11,710 systems in use globally.

Medical device competitors Medtronic and Johnson & Johnson are bringing out their own surgical robots.

Intuitive Surgical's largest revenue source isn't the sale of new da Vinci systems.

Intuitive Surgical (NASDAQ: ISRG) can be hard to own because the stock is prone to deep drawdowns. It is in a drawdown right now, with the stock down roughly 40% from its early 2025 high. Even after that drop, the price-to-earnings ratio remains lofty at 42x. This is not a stock for the faint of heart.

However, if you are a growth-oriented investor, you shouldn't give up on Intuitive Surgical. Historically, the stock has recovered from deep drawdowns and gone on to reach higher highs. There's a difference this time around due to increasing competition from medical device peers such as Medtronic (NYSE: MDT) and Johnson & Johnson (NYSE: JNJ) . But that probably shouldn't stop more aggressive investors. Here's why.

Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue ยป

Intuitive Surgical was an early leader in the surgical robotics space. The company's da Vinci system basically helped create the industry niche. So, early on, the question was about medical providers being willing to adopt a new technology. Surgical robotics is now a far more mature and well-accepted technology, generally enabling less invasive surgeries with better outcomes.

In late 2025, Medtronic received approval for its Hugo surgical robotic system in the United States. In mid-2026, J&J received approval for its OTTAVA surgical robot system. Both Medtronic and J&J are well-established competitors with strong industry connections. There is no doubt that they will be fierce competitors to Intuitive Surgical.

Read Full Story at Nasdaq News โ†’
Advertisement
" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "
โ€” Nasdaq News
React:
Sources
Sponsored

More to Read

I spent years in finance. Then I realized rural Japan's ricโ€ฆ
๐Ÿ“ˆ Markets & Finance
I spent years in finance. Then I realized rural Japan's rice terraces were an overlooked โ€ฆ
Business Insider Mkt ยท 9 days ago
Ethereum Foundation adds SEAL 911 co-founder to board as prโ€ฆ
๐Ÿ“ˆ Markets & Finance
Ethereum Foundation adds SEAL 911 co-founder to board as privacy focus grows
CoinTelegraph ยท 9 days ago
Higher Open Called For Indonesia Stock Market
๐Ÿ“ˆ Markets & Finance
Higher Open Called For Indonesia Stock Market
Nasdaq News ยท 10 days ago
Why Tesla Stock Crashed Today
๐Ÿ“ˆ Markets & Finance
Why Tesla Stock Crashed Today
Nasdaq News ยท 15 days ago
Hereโ€™s the biggest news you missed this weekend
๐ŸŒ World News
Hereโ€™s the biggest news you missed this weekend
NBC News ยท 12 days ago
ACC Portal Tracker
โšฝ Sports
ACC Portal Tracker
Yahoo Sports ยท 15 days ago
Full view